You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • FRI0315 Febuxostat May be Usefully Utilized for Allopurinol-Refractory Hyperuricemia in Gout Treatment of Dialysis Patients or Those in Stage 4 Chronic Kidney Disease (CKD)

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Bone diseases other than osteoporosis, metabolic diseases and crystal diseases
FRI0315 Febuxostat May be Usefully Utilized for Allopurinol-Refractory Hyperuricemia in Gout Treatment of Dialysis Patients or Those in Stage 4 Chronic Kidney Disease (CKD)

 

Online download statistics by month:

Online download statistics by month: June 2015 to March 2024

AbstractFullPdf
Jun 20151800
Jul 20152701
Aug 20153105
Sep 20155306
Oct 20152400
Nov 20152005
Dec 20153408
Jan 20163802
Feb 20163306
Mar 20162001
Apr 20163102
May 20162604
Jun 20162201
Jul 20161800
Aug 20162501
Sep 20162802
Oct 20162300
Nov 20161804
Dec 20161603
Jan 20171200
Feb 2017701
Mar 20171901
Apr 20171500
May 20172301
Jun 20171601
Jul 20172402
Aug 20174400
Sep 20173600
Oct 20175002
Nov 20173800
Dec 20171800
Jan 20181602
Feb 20182601
Mar 20182600
Apr 20182200
May 20182800
Jun 20183600
Jul 20181600
Aug 20181400
Sep 20182403
Oct 20181600
Nov 20182600
Dec 2018800
Jan 2019801
Feb 20191000
Mar 2019200
Apr 2019800
May 2019400
Jun 2019400
Jul 2019900
Aug 20192201
Sep 2019800
Oct 2019700
Nov 20191205
Dec 2019702
Jan 2020401
Feb 2020400
Mar 20201000
Apr 2020200
May 2020900
Jun 20201400
Jul 2020800
Aug 2020200
Sep 20202403
Oct 2020200
Nov 2020600
Dec 2020600
Jan 2021400
Feb 2021201
Mar 2021700
Apr 20212800
May 2021001
Jun 2021100
Sep 2021701
Oct 2021500
Nov 20211701
Dec 20211100
Jan 2022200
Feb 20221400
Mar 2022602
Apr 20221400
May 2022600
Jun 2022500
Jul 20221901
Aug 2022800
Sep 2022600
Oct 20221400
Nov 20221401
Dec 20221300
Jan 20231200
Feb 20231400
Mar 20231200
Apr 2023500
May 20231400
Jun 2023801
Jul 2023600
Sep 2023400
Oct 20232701
Dec 2023400
Jan 2024200
Feb 20241000
Mar 2024200
Total1580088